Pallidal lead placement in dystonia: leads of non-responders are contained within an anatomical range defined by responders

被引：0

作者：

Simone Zittel

Ute Hidding

Maria Trumpfheller

Vanessa Lupici Baltzer

Alessandro Gulberti

Miriam Schaper

Maxine Biermann

Carsten Buhmann

Andreas K. Engel

Christian Gerloff

Manfred Westphal

Jana Stadler

Johannes A. Köppen

Monika Pötter-Nerger

Christian K. E. Moll

Wolfgang Hamel

机构：

[1] University Medical Center Hamburg-Eppendorf,Department of Neurology

[2] Brainlab AG,Department of Neurophysiology and Pathophysiology

[3] University Medical Center Hamburg-Eppendorf,Department of Neurosurgery

[4] University Medical Center Hamburg-Eppendorf,undefined

来源：

Journal of Neurology | 2020年 / 267卷

关键词：

Dystonia; GPi stimulation; Deep brain stimulation; Volume of tissue activated (VTA); Clinical outcome;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1663 / 1671

页数：8

共 28 条

[21] Retreatment of HCV non-responders with peginterferon and ribavirin: Results from the lead-in phase of the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) Trial
Shiffman, M
HEPATOLOGY, 2002, 36 (04) : 295A - 295A
[22] Interferon dose increase for early (week 12) non-responders to interferon alfa-2b+ribavirin therapy for chronic hepatitis C does not lead to a viral response at 48 weeks.
Brau, N
Xiao, PY
Finch, DA
Lieber, CS
HEPATOLOGY, 2001, 34 (04) : 598A - 598A
[23] In HIV-Infected Immunological Non-Responders, Hepatitis C Virus Eradication Contributes to Incomplete Normalization of Systemic Inflammation Indexes, but Does Not Lead to Rapid CD4+T-Cell Count Recovery
Saidakova, E. V.
Korolevskaya, L. B.
Shmagel, N. G.
Vlasova, V. V.
Shardina, K. Yu.
Chereshnev, V. A.
Shmagel, K. V.
DOKLADY BIOCHEMISTRY AND BIOPHYSICS, 2023, 512 (01) : 274 - 278
[24] In HIV-Infected Immunological Non-Responders, Hepatitis C Virus Eradication Contributes to Incomplete Normalization of Systemic Inflammation Indexes, but Does Not Lead to Rapid CD4+ T-Cell Count Recovery
E. V. Saidakova
L. B. Korolevskaya
N. G. Shmagel
V. V. Vlasova
K. Yu. Shardina
V. A. Chereshnev
K. V. Shmagel
Doklady Biochemistry and Biophysics, 2023, 512 : 274 - 278
[25] Utility of historical data compared to lead-in response in predicting sustained virologic response in non-responders and relapsers to peginterferon/ribavirin when re-treated with boceprevir plus peginterferon alfa-2b/ribavirin
Bognar, F.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 96 - 96
[26] Utility of Historical Data Compared to Lead-in Response in Predicting Sustained Virologic Response in Non-Responders and Relapsers to Peginterferon/Ribavirin When Re-Treated With Boceprevir plus Peginterferon Alfa-2B/Ribavirin (PR)
Esteban, Rafael
Gordon, Stuart C.
Lawitz, Eric J.
Marcellin, Patrick
Vierling, John M.
Zeuzem, Stefan
Poordad, Fred
Boparai, Navdeep
Burroughs, Margaret
Albrecht, Janice K.
Brass, Clifford A.
Bacon, Bruce R.
GASTROENTEROLOGY, 2011, 140 (05) : S944 - S944
[27] UTILITY OF HISTORICAL DATA COMPARED TO LEAD-IN RESPONSE IN PREDICTING SUSTAINED VIROLOGIC RESPONSE IN NON-RESPONDERS AND RELAPSERS TO PEGINTERFERON/RIBAVIRIN WHEN RE-TREATED WITH BOCEPREVIR plus PEGINTERFERON ALFA-2B/RIBAVIRIN (P/R)
Esteban, R.
Gordon, S.
Lawitz, E.
Marcellin, P.
Vierlin, J.
Zeuzem, S.
Poordad, F.
Boparai, N.
Burroughs, M.
Albrecht, J.
Brass, C.
Bacon, B.
JOURNAL OF HEPATOLOGY, 2011, 54 : S168 - S169
[28] Utility of historical data compared to lead-in response in predicting sustained virologic response in non-responders and relapsers to peginterferon/ribavirin when re-treated with boceprevir plus peginterferon alfa-2b/ribavirin (P/R)
Bognar, F.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 21 - 21

← 1 2 3 →